Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Pfizer repels Covid-19 sales tumble to raise 2026 guidance

Fuelled by blockbusters such as Eliquis, Pfizer is cementing its post-Covid revenue legacy.

Robert Barrie

News

Supernus and Indivior merge to create scaled, CNS-focused entity

Annabel Kartal Allen

News

FDA grants breakthrough therapy designation to Lilly’s olomorasib

Salong Debbarma

News

AstraZeneca shares slump after $400bn BMS merger rumours

News

Curium to acquire Lantheus in all-cash deal worth up to $8bn

News

Amgen contends with data breach, exposing patient information

PremiumAnalyst Comment

What will health and social care look like under Andy Burnham?

News

Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns

Analysis

Analyst Comment

European drug manufacturers under threat from proposed US supply chain bill

GlobalData Healthcare

Analyst Comment

Cell and gene therapy manufacturers turn to specialist automation partners

GlobalData Healthcare

Analyst Comment

Australia approves first-in-class Niktimvo for later-line cGVHD

GlobalData Healthcare

Analyst Comment

FDA regenerative medicine approvals show growing momentum

GlobalData Healthcare

Themes

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

With regulatory conditions tightening around climate impact and environmental persistence of medical propellants, HFA-152a is a practical route to maintain clinical performance, patient outcomes and supply continuity of inhalers. However,...

More themes

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Partner Content

Turning AI skeptics into AI advocates through high-integrity data

Partner Content

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence

$495.00

Diabetic Macular Edema in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Type 2 Diabetes (T2D): Epidemiology Forecast to 2035

$9995.00

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Melanoma: Epidemiology Forecast to 2035

$9995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Supernus and Indivior merge to create scaled, CNS-focused entity

FDA grants breakthrough therapy designation to Lilly’s olomorasib

AstraZeneca shares slump after $400bn BMS merger rumours

Curium to acquire Lantheus in all-cash deal worth up to $8bn

Amgen contends with data breach, exposing patient information

What will health and social care look like under Andy Burnham?

Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns

European drug manufacturers under threat from proposed US supply chain bill

Cell and gene therapy manufacturers turn to specialist automation partners

Australia approves first-in-class Niktimvo for later-line cGVHD

FDA regenerative medicine approvals show growing momentum

Industry partnership will determine the success of the transition to low-GWP pMDIs

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence

Diabetic Macular Edema in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Type 2 Diabetes (T2D): Epidemiology Forecast to 2035

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Melanoma: Epidemiology Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence

Diabetic Macular Edema in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Type 2 Diabetes (T2D): Epidemiology Forecast to 2035

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Melanoma: Epidemiology Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing